Breaking News
9 hours ago
Team Pharma Now
Mumbai Biocluster announces Biologics X 3DCC Summit 2026, uniting biologics and 3D cell culture leaders to accelerate next-gen biopharma innovation.
Team Pharma Now
ErlySign completes a 1,000-patient clinical trial for India’s first salivary biomarker test for early oral cancer, targeting market launch in 2026.
Team Pharma Now
Cartesian names industry veteran Adrian Bot to its Board of Directors, adding deep expertise in CAR T, RNA, and immune therapies.
Simantini Singh Deo
Alvotech and Teva secure a U.S. settlement with Regeneron, paving the way for AVT06 Eylea biosimilar launch in 2026.
Simantini Singh Deo